§ Funding Round
Series B funding round for Pionyr Immunotherapeutics raising $62M in December 2017
Series B funding round for Pionyr Immunotherapeutics raising $62M in December 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
New Enterprise AssociatesLEAD | — | — |
Omega Funds | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Leon Chen | — | — |
| Organization | — | |
| Angel | michael powell | |
| Angel | joshua resnick |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$70M
Top Valuation
-
Pionyr Immunotherapeutics raised $62M in a Series B round.
The round was announced on 12/01/17.
The round was led by New Enterprise Associates.
